Southern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance

Qiu Sue Huang, Nikki Turner, Michael G. Baker, Deborah A. Williamson, Conroy Wong, Richard Webby, Marc Alain Widdowson, on behalf of the SHIVERS investigation team

Research output: Contribution to journalReview ArticleResearchpeer-review

Abstract

The 2009 influenza A(H1N1)pdm09 pandemic highlighted the need for improved scientific knowledge to support better pandemic preparedness and seasonal influenza control. The Southern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance (SHIVERS) project, a 5-year (2012-2016) multiagency and multidisciplinary collaboration, aimed to measure disease burden, epidemiology, aetiology, risk factors, immunology, effectiveness of vaccination and other prevention strategies for influenza and other respiratory infectious diseases of public health importance. Two active, prospective, population-based surveillance systems were established for monitoring influenza and other respiratory pathogens among those hospitalized patients with acute respiratory illness and those enrolled patients seeking consultations at sentinel general practices. In 2015, a sero-epidemiological study will use a sample of patients from the same practices. These data will provide a full picture of the disease burden and risk factors from asymptomatic infections to severe hospitalized disease and deaths and related economic burden. The results during the first 2 years (2012-2013) provided scientific evidence to (a) support a change to NZ's vaccination policy for young children due to high influenza hospitalizations in these children; (b) contribute to the revision of the World Health Organization's case definition for severe acute respiratory illness for global influenza surveillance; and (c) contribute in part to vaccine strain selection using vaccine effectiveness assessment in the prevention of influenza-related consultations and hospitalizations. In summary, SHIVERS provides valuable international platforms for supporting seasonal influenza control and pandemic preparedness, and responding to other emerging/endemic respiratory-related infections.

Original languageEnglish
Pages (from-to)179-190
Number of pages12
JournalInfluenza and other Respiratory Viruses
Volume9
Issue number4
DOIs
Publication statusPublished - 1 Jul 2015

Keywords

  • Disease burden
  • Epidemiology
  • Immunology
  • Influenza
  • Risk factors
  • Vaccine effectiveness

Cite this

Huang, Q. S., Turner, N., Baker, M. G., Williamson, D. A., Wong, C., Webby, R., ... on behalf of the SHIVERS investigation team (2015). Southern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance. Influenza and other Respiratory Viruses, 9(4), 179-190. https://doi.org/10.1111/irv.12315
Huang, Qiu Sue ; Turner, Nikki ; Baker, Michael G. ; Williamson, Deborah A. ; Wong, Conroy ; Webby, Richard ; Widdowson, Marc Alain ; on behalf of the SHIVERS investigation team. / Southern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance. In: Influenza and other Respiratory Viruses. 2015 ; Vol. 9, No. 4. pp. 179-190.
@article{5c5e5af452f240b4b6ff0693e7b9e56e,
title = "Southern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance",
abstract = "The 2009 influenza A(H1N1)pdm09 pandemic highlighted the need for improved scientific knowledge to support better pandemic preparedness and seasonal influenza control. The Southern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance (SHIVERS) project, a 5-year (2012-2016) multiagency and multidisciplinary collaboration, aimed to measure disease burden, epidemiology, aetiology, risk factors, immunology, effectiveness of vaccination and other prevention strategies for influenza and other respiratory infectious diseases of public health importance. Two active, prospective, population-based surveillance systems were established for monitoring influenza and other respiratory pathogens among those hospitalized patients with acute respiratory illness and those enrolled patients seeking consultations at sentinel general practices. In 2015, a sero-epidemiological study will use a sample of patients from the same practices. These data will provide a full picture of the disease burden and risk factors from asymptomatic infections to severe hospitalized disease and deaths and related economic burden. The results during the first 2 years (2012-2013) provided scientific evidence to (a) support a change to NZ's vaccination policy for young children due to high influenza hospitalizations in these children; (b) contribute to the revision of the World Health Organization's case definition for severe acute respiratory illness for global influenza surveillance; and (c) contribute in part to vaccine strain selection using vaccine effectiveness assessment in the prevention of influenza-related consultations and hospitalizations. In summary, SHIVERS provides valuable international platforms for supporting seasonal influenza control and pandemic preparedness, and responding to other emerging/endemic respiratory-related infections.",
keywords = "Disease burden, Epidemiology, Immunology, Influenza, Risk factors, Vaccine effectiveness",
author = "Huang, {Qiu Sue} and Nikki Turner and Baker, {Michael G.} and Williamson, {Deborah A.} and Conroy Wong and Richard Webby and Widdowson, {Marc Alain} and {on behalf of the SHIVERS investigation team} and Colin McArthur",
year = "2015",
month = "7",
day = "1",
doi = "10.1111/irv.12315",
language = "English",
volume = "9",
pages = "179--190",
journal = "Influenza and other Respiratory Viruses",
issn = "1750-2640",
publisher = "Wiley-Blackwell",
number = "4",

}

Huang, QS, Turner, N, Baker, MG, Williamson, DA, Wong, C, Webby, R, Widdowson, MA & on behalf of the SHIVERS investigation team 2015, 'Southern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance' Influenza and other Respiratory Viruses, vol. 9, no. 4, pp. 179-190. https://doi.org/10.1111/irv.12315

Southern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance. / Huang, Qiu Sue; Turner, Nikki; Baker, Michael G.; Williamson, Deborah A.; Wong, Conroy; Webby, Richard; Widdowson, Marc Alain; on behalf of the SHIVERS investigation team.

In: Influenza and other Respiratory Viruses, Vol. 9, No. 4, 01.07.2015, p. 179-190.

Research output: Contribution to journalReview ArticleResearchpeer-review

TY - JOUR

T1 - Southern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance

AU - Huang, Qiu Sue

AU - Turner, Nikki

AU - Baker, Michael G.

AU - Williamson, Deborah A.

AU - Wong, Conroy

AU - Webby, Richard

AU - Widdowson, Marc Alain

AU - on behalf of the SHIVERS investigation team

AU - McArthur, Colin

PY - 2015/7/1

Y1 - 2015/7/1

N2 - The 2009 influenza A(H1N1)pdm09 pandemic highlighted the need for improved scientific knowledge to support better pandemic preparedness and seasonal influenza control. The Southern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance (SHIVERS) project, a 5-year (2012-2016) multiagency and multidisciplinary collaboration, aimed to measure disease burden, epidemiology, aetiology, risk factors, immunology, effectiveness of vaccination and other prevention strategies for influenza and other respiratory infectious diseases of public health importance. Two active, prospective, population-based surveillance systems were established for monitoring influenza and other respiratory pathogens among those hospitalized patients with acute respiratory illness and those enrolled patients seeking consultations at sentinel general practices. In 2015, a sero-epidemiological study will use a sample of patients from the same practices. These data will provide a full picture of the disease burden and risk factors from asymptomatic infections to severe hospitalized disease and deaths and related economic burden. The results during the first 2 years (2012-2013) provided scientific evidence to (a) support a change to NZ's vaccination policy for young children due to high influenza hospitalizations in these children; (b) contribute to the revision of the World Health Organization's case definition for severe acute respiratory illness for global influenza surveillance; and (c) contribute in part to vaccine strain selection using vaccine effectiveness assessment in the prevention of influenza-related consultations and hospitalizations. In summary, SHIVERS provides valuable international platforms for supporting seasonal influenza control and pandemic preparedness, and responding to other emerging/endemic respiratory-related infections.

AB - The 2009 influenza A(H1N1)pdm09 pandemic highlighted the need for improved scientific knowledge to support better pandemic preparedness and seasonal influenza control. The Southern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance (SHIVERS) project, a 5-year (2012-2016) multiagency and multidisciplinary collaboration, aimed to measure disease burden, epidemiology, aetiology, risk factors, immunology, effectiveness of vaccination and other prevention strategies for influenza and other respiratory infectious diseases of public health importance. Two active, prospective, population-based surveillance systems were established for monitoring influenza and other respiratory pathogens among those hospitalized patients with acute respiratory illness and those enrolled patients seeking consultations at sentinel general practices. In 2015, a sero-epidemiological study will use a sample of patients from the same practices. These data will provide a full picture of the disease burden and risk factors from asymptomatic infections to severe hospitalized disease and deaths and related economic burden. The results during the first 2 years (2012-2013) provided scientific evidence to (a) support a change to NZ's vaccination policy for young children due to high influenza hospitalizations in these children; (b) contribute to the revision of the World Health Organization's case definition for severe acute respiratory illness for global influenza surveillance; and (c) contribute in part to vaccine strain selection using vaccine effectiveness assessment in the prevention of influenza-related consultations and hospitalizations. In summary, SHIVERS provides valuable international platforms for supporting seasonal influenza control and pandemic preparedness, and responding to other emerging/endemic respiratory-related infections.

KW - Disease burden

KW - Epidemiology

KW - Immunology

KW - Influenza

KW - Risk factors

KW - Vaccine effectiveness

UR - http://www.scopus.com/inward/record.url?scp=84930793982&partnerID=8YFLogxK

U2 - 10.1111/irv.12315

DO - 10.1111/irv.12315

M3 - Review Article

VL - 9

SP - 179

EP - 190

JO - Influenza and other Respiratory Viruses

JF - Influenza and other Respiratory Viruses

SN - 1750-2640

IS - 4

ER -